Impact of Continuous Glucose Monitoring (CGM) on Hypoglycemia in T1D Adults on Multiple Daily Insulin Injections (MDI)

被引：0

|

作者：

Olafsdottir, Arndis F.

Hirsch, Irl B.

Bolinder, Jan

Heise, Tim

Polonsky, William H.

Dahlqvist, Sofia

Frid, Anders

Ahlen, Elsa

Hellman, Jarl

Wedel, Hans

Lind, Marcus

机构：

来源：

DIABETES | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

932-P

引用

收藏

页码：A240 / A240

页数：1

相关论文

共 50 条

[41] The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes
Johnson, Susan L.
McEwen, Laura N.
Newton, Christopher A.
Martin, Catherine L.
Raskin, Philip
Halter, Jeffrey B.
Herman, William H.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2011, 25 (04) : 211 - 215
[42] Differences in continuous glucose monitoring (CGM) metrics in minoritized children with a new type 1 diabetes (T1D) diagnosis
Barber, R.
Zeier, T.
Raymond, J.
Chao, L.
HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 157 - 157
[43] Evaluating Early Initiation of Continuous Glucose Monitoring (CGM) among Youth Diagnosed with Type 1 Diabetes (T1D)
Wong, Jessie J.
Clay, Susan Michelle
Forlenza, Gregory P.
Hanes, Sarah
Wadwa, R. Paul
Hood, Korey K.
DIABETES, 2019, 68
[44] Frequency of Continuous Glucose Monitoring (CGM) Wear in Youth with Type 1 Diabetes (T1D): Association with Psychosocial Variables
Snelgrove, Rebecca K.
Markowitz, Jessica T.
Volkening, Lisa
Kao, Anita
Busha, Ryan
Laffel, Lori M.
DIABETES, 2015, 64 : A222 - A222
[45] Transition from Multiple Daily Injections (MDI) to Omnipod 5 Automated Insulin Delivery System Improves A1C in Type 1 Diabetes (T1D)
Shah, Viral
Criego, Amy B.
Carlson, Anders L.
Bhargava, Anuj
Bode, Bruce W.
Brown, Sue A.
Forlenza, Gregory P.
Levy, Carol J.
Mehta, Sanjeev N.
Laffel, Lori M.
Aleppo, Grazia
Buckingham, Bruce A.
Desalvo, Daniel
Hirsch, Irl B.
Macleish, Sarah A.
Pinsker, Jordan E.
Ly, Trang T.
DIABETES, 2021, 70
[46] Glucose Levels Assessed by Continuous Glucose Monitoring (CGM) across the Pediatric Age Range in Youth with Type 1 Diabetes (T1D)
Laffel, Lori M.
Bailey, Timothy S.
Ahmann, Andrew J.
Tsalikian, Eva
Chase, Peter
DIABETES, 2015, 64 : A364 - A364
[47] Motivation and Attitudinal Assessment in Patients with T1D Using Multiple Daily Injections or Insulin Pump Therapy
Alford, Jordin
Koobatian, Maxwell
Daigle, Ben
Mathews, Kieron
Dias, Louis
DIABETES, 2019, 68
[48] Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)-A United States Perspective
Kommareddi, Mallika
Wherry, Kael
DIABETES, 2023, 72
[49] Utilization of Continuous Glucose Monitoring (CGM) among Older Adults with Type 1 Diabetes (T1D)-An Analysis of Real-World Clinical Data
Kahkoska, Anna R.
Weinstein, Joshua M.
Muthukkumar, Rashmi
Young, Laura A.
DIABETES, 2023, 72
[50] Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a US Payer Perspective in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (PwT2D on MDI)
Alshannaq, Hamza
Norman, Gregory J.
Lynch, Peter M.
DIABETES, 2023, 72

← 1 2 3 4 5 →